Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury

Neuroscience Letters

Volumn 438, Issue 2, 2008, Pages 200-204

  Whitaker, Christopher M ^a   Beaumont, Eric ^a   Wells, Michael J ^a   Magnuson, David S K ^a   Hetman, Michal ^a   Onifer, Stephen M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

APC; cAMP; Microglia; OX 42; Phosphodiesterase 4; White matter

Indexed keywords

PHOSPHODIESTERASE IV; PROTEIN SUBUNIT; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CERVICAL SPINAL CORD INJURY; CONTROLLED STUDY; CONTUSION; DRUG TARGETING; FEMALE; GLIA CELL; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; WHITE MATTER;

ANIMALS; ANTIGENS, CD11B; APOPTOSIS; CELL SURVIVAL; CERVICAL VERTEBRAE; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DISEASE MODELS, ANIMAL; EFFERENT PATHWAYS; FEMALE; ISOENZYMES; MICROGLIA; NERVE FIBERS, MYELINATED; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS; WALLERIAN DEGENERATION;

EID: 43849085016     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.03.087     Document Type: Article

References (59)

1. Anderson D.K., and Hall E.D. Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22 (1993) 987-992
2. Bartholdi D., and Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 9 (1997) 1422-1438
3. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., and Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18 (1998) 3251-3260
4. Bhat R.V., Axt K.J., Fosnaugh J.S., Smith K.J., Johnson K.A., Hill D.E., Kinzler K.W., and Baraban J.M. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17 (1996) 169-174
5. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25 (2004) 280-288
6. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., and Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59 (1993) 75-89
7. Cao Q., Xu X.M., Devries W.H., Enzmann G.U., Ping P., Tsoulfas P., Wood P.M., Bunge M.B., and Whittemore S.R. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J. Neurosci. 25 (2005) 6947-6957
8. Carmel J.B., Galante A., Soteropoulos P., Tolias P., Recce M., Young W., and Hart R.P. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol. Genom. 7 (2001) 201-213
9. Casella G.T., Bunge M.B., and Wood P.M. Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp. Neurol. 202 (2006) 8-20
10. Chen R.W., Williams A.J., Liao Z., Yao C., Tortella F.C., and Dave J.R. Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation. Neurosci. Lett. 418 (2007) 165-169
11. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., and Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3 (1997) 73-76
12. Emery E., Aldana P., Bunge M.B., Puckett W., Srinivasan A., Keane R.W., Bethea J., and Levi A.D. Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89 (1998) 911-920
13. Grossman S.D., Rosenberg L.J., and Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 168 (2001) 273-282
14. Grossman S.D., Wolfe B.B., Yasuda R.P., and Wrathall J.R. Changes in NMDA receptor subunit expression in response to contusive spinal cord injury. J. Neurochem. 75 (2000) 174-184
15. Guest J.D., Hiester E.D., and Bunge R.P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192 (2005) 384-393
16. Hajjhussein H., Suvarna N.U., Gremillion C., Chandler L.J., and O'Donnell J.M. Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures. Brain Res. 1149 (2007) 58-68
17. Hannila S.S., and Filbin M.T. The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp. Neurol. 209 (2008) 321-332
18. Hill E.V., Sheppard C.L., Cheung Y.F., Gall I., Krause E., and Houslay M.D. Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579. Cell Signal 18 (2006) 2056-2069
19. Jaworski J., Mioduszewska B., Sanchez-Capelo A., Figiel I., Habas A., Gozdz A., Proszynski T., Hetman M., Mallet J., and Kaczmarek L. Inducible cAMP early repressor, an endogenous antagonist of cAMP responsive element-binding protein, evokes neuronal apoptosis in vitro. J. Neurosci. 23 (2003) 4519-4526
20. Jin S.L., and Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7628-7633
21. Jin S.L., Lan L., Zoudilova M., and Conti M. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J. Immunol. 175 (2005) 1523-1531
22. Karadottir R., and Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 145 (2007) 1426-1438
23. Keane R.W., Davis A.R., and Dietrich W.D. Inflammatory and apoptotic signaling after spinal cord injury. J. Neurotrauma 23 (2006) 335-344
24. Koshinaga M., and Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 12 (1995) 209-222
25. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., and Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17 (1997) 5395-5406
26. Louis J.C., Magal E., Takayama S., and Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259 (1993) 689-692
27. Loy D.N., Crawford C.H., Darnall J.B., Burke D.A., Onifer S.M., and Whittemore S.R. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J. Comp. Neurol. 445 (2002) 308-324
28. Loy D.N., Magnuson D.S., Zhang Y.P., Onifer S.M., Mills M.D., Cao Q.L., Darnall J.B., Fajardo L.C., Burke D.A., and Whittemore S.R. Functional redundancy of ventral spinal locomotor pathways. J. Neurosci. 22 (2002) 315-323
29. Loy D.N., Talbott J.F., Onifer S.M., Mills M.D., Burke D.A., Dennison J.B., Fajardo L.C., Magnuson D.S., and Whittemore S.R. Both dorsal and ventral spinal cord pathways contribute to overground locomotion in the adult rat. Exp. Neurol. 177 (2002) 575-580
30. Lu P., Yang H., Jones L.L., Filbin M.T., and Tuszynski M.H. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24 (2004) 6402-6409
31. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109 (2006) 366-398
32. Ma D., Wu P., Egan R.W., Billah M.M., and Wang P. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes. Mol. Pharmacol. 55 (1999) 50-57
33. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G., Silver J., and Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 209 (2008) 426-445
34. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A., and Sanchez-Gomez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24 (2001) 224-230
35. McEwen M.L., and Springer J.E. A mapping study of caspase-3 activation following acute spinal cord contusion in rats. J. Histochem. Cytochem. 53 (2005) 809-819
36. McTigue D.M., Wei P., and Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 21 (2001) 3392-3400
37. Miller B.A., Sun F., Christensen R.N., Ferguson A.R., Bresnahan J.C., and Beattie M.S. A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes. Neurochem. Res. 30 (2005) 867-875
38. Nikulina E., Tidwell J.L., Dai H.N., Bregman B.S., and Filbin M.T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8786-8790
39. Onifer S.M., Nunn C.D., Decker J.A., Payne B.N., Wagoner M.R., Puckett A.H., Massey J.M., Armstrong J., Kaddumi E.G., Fentress K.G., Wells M.J., West R.M., Calloway C.C., Schnell J.T., Whitaker C.M., Burke D.A., and Hubscher C.H. Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury. Exp. Neurol. 207 (2007) 238-247
40. Onifer S.M., Zhang Y.P., Burke D.A., Brooks D.L., Decker J.A., McClure N.J., Floyd A.R., Hall J., Proffitt B.L., Shields C.B., and Magnuson D.S. Adult rat forelimb dysfunction after dorsal cervical spinal cord injury. Exp. Neurol. 192 (2005) 25-38
41. Pang X.P., Ross N.S., Park M., Juillard G.J., Stanley T.M., and Hershman J.M. Tumor necrosis factor-alpha activates nuclear factor kappa B and induces manganous superoxide dismutase and phosphodiesterase mRNA in human papillary thyroid carcinoma cells. J. Biol. Chem. 267 (1992) 12826-12830
42. Park E., Velumian A.A., and Fehlings M.G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma 21 (2004) 754-774
43. Patrizio M. Tumor necrosis factor reduces cAMP production in rat microglia. Glia 48 (2004) 241-249
44. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., and Bunge M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10 (2004) 610-616
45. Pineau I., and Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500 (2007) 267-285
46. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
47. Rabchevsky A.G., Sullivan P.G., and Scheff S.W. Temporal-spatial dynamics in oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white matter following contusion spinal cord injury. Glia 55 (2007) 831-843
48. Sachs B.D., Baillie G.S., McCall J.R., Passino M.A., Schachtrup C., Wallace D.A., Dunlop A.J., MacKenzie K.F., Klussmann E., Lynch M.J., Sikorski S.L., Nuriel T., Tsigelny I., Zhang J., Houslay M.D., Chao M.V., and Akassoglou K. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol. 177 (2007) 1119-1132
49. Scheff S.W., Rabchevsky A.G., Fugaccia I., Main J.A., and Lumpp Jr. J.E. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma. 20 (2003) 179-193
50. Selmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346
51. Stys P.K. White matter injury mechanisms. Curr. Mol. Med. 4 (2004) 113-130
52. Totoiu M.O., and Keirstead H.S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 486 (2005) 373-383
53. Tripathi R., and McTigue D.M. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 55 (2007) 698-711
54. Vicini E., and Conti M. Characterization of an intronic promoter of a cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol. Endocrinol. 11 (1997) 839-850
55. Wachtel H. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′, 5′-monophosphate phosphodiesterase inhibitors. Psychopharmacol. (Berl.) 77 (1982) 309-316
56. Yan P., Liu N., Kim G.M., Xu J., Xu J., Li Q., Hsu C.Y., and Xu X.M. Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats. Exp. Neurol. 183 (2003) 286-297
57. Yoshikawa M., Suzumura A., Tamaru T., Takayanagi T., and Sawada M. Effects of phosphodiesterase inhibitors on cytokine production by microglia. Mult. Scler. 5 (1999) 126-133
58. Yoshioka A., Shimizu Y., Hirose G., Kitasato H., and Pleasure D. Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. J. Neurochem. 70 (1998) 2416-2423
59. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., and Pleasure D. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J. Neurochem. 74 (2000) 633-640